Zobrazeno 1 - 10
of 535
pro vyhledávání: '"McGhee EJ"'
Autor:
Samuel MS, Lopez JI, McGhee EJ, Croft DR, Strachan D, Timpson P, Munro J, Schröder E, Zhou J, Brunton VG, Barker N, Clevers H, Sansom OJ, Anderson KI, Weaver VM, Olson MF
Publikováno v:
Cancer cell [Cancer Cell] 2024 Feb 12; Vol. 42 (2), pp. 317.
Autor:
Reid, SE, Kay, EJ, Neilson, LJ, Henze, AT, Serneels, J, McGhee, EJ, Dhayade, S, Nixon, C, Mackey, JB, Santi, A, Swaminathan, Karthic, Athineos, D, Papalazarou, V, Patella, F, Roman-Fernandez, A, ElMaghloob, Y, Hernandez-Fernaud, JR, Adams, RH, Ismail, S, Bryant, DM, Salmeron-Sanchez, M, Machesky, LM, Carlin, LM, Blyth, K, Mazzone, M, Zanivan, S
Yes
Tumor progression alters the composition and physical properties of the extracellular matrix. Particularly, increased matrix stiffness has profound effects on tumor growth and metastasis. While endothelial cells are key players in cancer pro
Tumor progression alters the composition and physical properties of the extracellular matrix. Particularly, increased matrix stiffness has profound effects on tumor growth and metastasis. While endothelial cells are key players in cancer pro
Externí odkaz:
http://hdl.handle.net/10454/17727
Autor:
Vennin, C, Chin, VT, Warren, SC, Lucas, MC, Herrmann, D, Magenau, A, Melenec, P, Walters, SN, Del Monte-Nieto, G, Conway, JRW, Nobis, M, Allam, AH, McCloy, RA, Currey, N, Pinese, M, Boulghourjian, A, Zaratzian, A, Adam, AAS, Heu, C, Nagrial, AM, Chou, A, Steinmann, A, Drury, A, Froio, D, Giry-Laterriere, M, Harris, NLE, Phan, T, Jain, R, Weninger, W, McGhee, EJ, Whan, R, Johns, AL, Samra, JS, Chantrill, L, Gill, AJ, Kohonen-Corish, M, Harvey, RP, Biankin, AV, Australian Pancreatic Cancer Genome Initiative (APGI), Evans, TRJ, Anderson, KI, Grey, ST, Ormandy, CJ, Gallego-Ortega, D, Wang, Y, Samuel, MS, Sansom, OJ, Burgess, A, Cox, TR, Morton, JP, Pajic, M, Timpson, P
The emerging standard of care for patients with inoperable pancreatic cancer is a combination of cytotoxic drugs gemcitabine and Abraxane, but patient response remains moderate. Pancreatic cancer development and metastasis occur in complex settings,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::0d5a9b78d701c3ded4723929d771cffb
https://hdl.handle.net/10453/156230
https://hdl.handle.net/10453/156230
Autor:
Ntala C; CRUK Beatson Institute, Glasgow, UK.; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, UK., Salji M; CRUK Beatson Institute, Glasgow, UK.; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, UK., Salmond J; Department of Pathology, Queen Elizabeth University Hospital, Glasgow, UK., Officer L; CRUK Beatson Institute, Glasgow, UK.; Medical Research Council Toxicology Unit, University of Cambridge, Leicester, UK., Teodosio AV; Medical Research Council Toxicology Unit, University of Cambridge, Leicester, UK., Blomme A; CRUK Beatson Institute, Glasgow, UK., McGhee EJ; CRUK Beatson Institute, Glasgow, UK., Powley I; CRUK Beatson Institute, Glasgow, UK.; Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Ahmad I; CRUK Beatson Institute, Glasgow, UK.; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, UK., Kruithof-de Julio M; Department of Urology, Bern University Hospital, University of Bern, Bern, Switzerland., Thalmann G; Department of Urology, Bern University Hospital, University of Bern, Bern, Switzerland., Roberts E; CRUK Beatson Institute, Glasgow, UK., Goodyear CS; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK., Jamaspishvili T; Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada., Berman DM; Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada., Carlin LM; CRUK Beatson Institute, Glasgow, UK.; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, UK., Le Quesne J; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, UK.; Medical Research Council Toxicology Unit, University of Cambridge, Leicester, UK.; Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Leung HY; CRUK Beatson Institute, Glasgow, UK.; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, UK.
Publikováno v:
European urology open science [Eur Urol Open Sci] 2021 May 25; Vol. 29, pp. 19-29. Date of Electronic Publication: 2021 May 25 (Print Publication: 2021).
Autor:
Bradford, C, Urbaszek, B, Funato, M, Graham, TCM, McGhee, EJ, Warburton, RJ, Prior, KA, Cavenett, B
Publikováno v:
JOURNAL OF CRYSTAL GROWTH. 251(1-4):581-585
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::daa15416e794ce2795fa4ffd975fab22
http://hdl.handle.net/2433/3249
http://hdl.handle.net/2433/3249
Autor:
Myant KB, Cammareri P, McGhee EJ, Ridgway RA, Huels DJ, Cordero JB, Schwitalla S, Kalna G, Ogg EL, Athineos D, Timpson P, Vidal M, Murray GI, Greten FR, Anderson KI, Sansom OJ.
Publikováno v:
Cell Stem Cell.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=erc_________::a6c7f32f7e4d534071bc829013c2279a
Autor:
Puttur F; Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, UK., Denney L; Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, UK., Gregory LG; Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, UK., Vuononvirta J; Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, UK., Oliver R; Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, UK., Entwistle LJ; Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, UK., Walker SA; Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, UK., Headley MB; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., McGhee EJ; Cancer Research UK Beatson Institute, Garscube Estate, Bearsden, Glasgow, UK., Pease JE; Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, UK., Krummel MF; Department of Pathology, University of California, San Francisco, 513 Parnassus Ave., San Francisco, CA, USA., Carlin LM; Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, UK. c.lloyd@imperial.ac.uk l.carlin@beatson.gla.ac.uk.; Cancer Research UK Beatson Institute, Garscube Estate, Bearsden, Glasgow, UK.; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Lloyd CM; Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, UK. c.lloyd@imperial.ac.uk l.carlin@beatson.gla.ac.uk.
Publikováno v:
Science immunology [Sci Immunol] 2019 Jun 07; Vol. 4 (36).
Autor:
Talbot, CB, McGinty, J, Grant, DM, McGhee, EJ, Owen, DM, Zhang, W, Bunney, TD, Munro, I, Isherwood, B, Eagle, R, Hargreaves, A, Katan, M, Dunsby, C, Neil, MAA, French, PMW
We report an automated optically sectioning fluorescence lifetime imaging (FLIM) multiwell plate reader for high content analysis (HCA) in drug discovery and accelerated research in cell biology. The system utilizes a Nipkow disc confocal microscope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56b9640e9140354a6f74ec293d42b590
http://hdl.handle.net/10044/1/19121
http://hdl.handle.net/10044/1/19121
Autor:
Candido JB; Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK., Morton JP; Cancer Research UK Beatson Institute, Glasgow G61 1BD, UK; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK., Bailey P; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK., Campbell AD; Cancer Research UK Beatson Institute, Glasgow G61 1BD, UK., Karim SA; Cancer Research UK Beatson Institute, Glasgow G61 1BD, UK., Jamieson T; Cancer Research UK Beatson Institute, Glasgow G61 1BD, UK., Lapienyte L; Cancer Research UK Beatson Institute, Glasgow G61 1BD, UK., Gopinathan A; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK., Clark W; Cancer Research UK Beatson Institute, Glasgow G61 1BD, UK., McGhee EJ; Cancer Research UK Beatson Institute, Glasgow G61 1BD, UK., Wang J; Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK., Escorcio-Correia M; Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK., Zollinger R; Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK., Roshani R; Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK., Drew L; Bioscience, Oncology, iMED Biotech Unit, AstraZeneca, Boston, MA, USA., Rishi L; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK., Arkell R; Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK., Evans TRJ; Cancer Research UK Beatson Institute, Glasgow G61 1BD, UK; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK., Nixon C; Cancer Research UK Beatson Institute, Glasgow G61 1BD, UK., Jodrell DI; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK., Wilkinson RW; MedImmune Ltd, Granta Park, Cambridge CB21 6GH, UK., Biankin AV; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK., Barry ST; Bioscience, Oncology, iMED Biotech Unit, AstraZeneca, Cambridge, UK., Balkwill FR; Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK., Sansom OJ; Cancer Research UK Beatson Institute, Glasgow G61 1BD, UK; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK. Electronic address: o.sansom@beatson.gla.ac.uk.
Publikováno v:
Cell reports [Cell Rep] 2018 May 01; Vol. 23 (5), pp. 1448-1460.
Autor:
Martin KJ; Beatson Institute for Cancer Research, Glasgow, United Kingdom., McGhee EJ; Beatson Institute for Cancer Research, Glasgow, United Kingdom., Schwarz JP; Beatson Institute for Cancer Research, Glasgow, United Kingdom., Drysdale M; Beatson Institute for Cancer Research, Glasgow, United Kingdom., Brachmann SM; Novartis Institutes for Biomedical Research, Basel, Switzerland., Stucke V; Novartis Institutes for Biomedical Research, Basel, Switzerland., Sansom OJ; Beatson Institute for Cancer Research, Glasgow, United Kingdom., Anderson KI; Beatson Institute for Cancer Research, Glasgow, United Kingdom.
Publikováno v:
PloS one [PLoS One] 2018 Jan 02; Vol. 13 (1), pp. e0183585. Date of Electronic Publication: 2018 Jan 02 (Print Publication: 2018).